这是一篇来自已证抗体库的有关鸡 PAX2的综述,是根据6篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合PAX2 抗体。
PAX2 同义词: PAX-2

BioLegend
domestic rabbit 多克隆(Poly19010)
  • 免疫细胞化学; 人类; 1:1000; 图 2a
BioLegend PAX2抗体(Biolegend, 901001)被用于被用于免疫细胞化学在人类样本上浓度为1:1000 (图 2a). Sci Rep (2021) ncbi
domestic rabbit 多克隆(Poly19010)
  • 免疫组化; 小鼠; 1:200; 图 1a
BioLegend PAX2抗体(Covance, PRB-276P)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 1a). Science (2017) ncbi
domestic rabbit 多克隆(Poly19010)
  • 免疫组化; 小鼠; 1:300; 图 1
BioLegend PAX2抗体(Covance, PRB-276P)被用于被用于免疫组化在小鼠样本上浓度为1:300 (图 1). Nat Commun (2016) ncbi
domestic rabbit 多克隆(Poly19010)
  • 免疫细胞化学; 小鼠; 1:200; 图 8d
BioLegend PAX2抗体(Biolegend, PRB-276P)被用于被用于免疫细胞化学在小鼠样本上浓度为1:200 (图 8d). PLoS ONE (2016) ncbi
domestic rabbit 多克隆(Poly19010)
  • 免疫组化-石蜡切片; 小鼠; 1:250; 图 5
  • 免疫组化; 小鼠; 1:300; 图 6
BioLegend PAX2抗体(BioLegend, 901001)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:250 (图 5) 和 被用于免疫组化在小鼠样本上浓度为1:300 (图 6). Sci Rep (2016) ncbi
domestic rabbit 多克隆(Poly19010)
  • 免疫组化; 斑马鱼; 1:300; 图 2
BioLegend PAX2抗体(Covance, PRB-276P)被用于被用于免疫组化在斑马鱼样本上浓度为1:300 (图 2). Neural Dev (2016) ncbi
文章列表
  1. Yamamura Y, Furuichi K, Murakawa Y, Hirabayashi S, Yoshihara M, Sako K, et al. Identification of candidate PAX2-regulated genes implicated in human kidney development. Sci Rep. 2021;11:9123 pubmed 出版商
  2. Zhao F, Franco H, Rodriguez K, Brown P, Tsai M, Tsai S, et al. Elimination of the male reproductive tract in the female embryo is promoted by COUP-TFII in mice. Science. 2017;357:717-720 pubmed 出版商
  3. Reginensi A, Enderle L, Gregorieff A, Johnson R, Wrana J, McNeill H. A critical role for NF2 and the Hippo pathway in branching morphogenesis. Nat Commun. 2016;7:12309 pubmed 出版商
  4. Dauleh S, Santeramo I, Fielding C, Ward K, Herrmann A, Murray P, et al. Characterisation of Cultured Mesothelial Cells Derived from the Murine Adult Omentum. PLoS ONE. 2016;11:e0158997 pubmed 出版商
  5. Zhao F, Zhou J, Li R, Dudley E, Ye X. Novel function of LHFPL2 in female and male distal reproductive tract development. Sci Rep. 2016;6:23037 pubmed 出版商
  6. Juárez Morales J, Schulte C, Pezoa S, Vallejo G, Hilinski W, England S, et al. Evx1 and Evx2 specify excitatory neurotransmitter fates and suppress inhibitory fates through a Pax2-independent mechanism. Neural Dev. 2016;11:5 pubmed 出版商